|
102
|
391
|
7n66A |
Bace-1 in complex with ligand 12 |
|
90
|
386
|
7n4nA |
Bace-2 in complex with ligand 36 |
|
84
|
330
|
7adgA |
Cocktail experiment g: fragments 216 and 338 at 90 mm concentration in complex with endothiapepsin |
|
83
|
330
|
6zz2A |
Cocktail experiment e: fragments 52, 58, and 63 at 90 mm concentration in complex with endothiapepsin |
|
84
|
330
|
5sapA |
Endothiapepsin in complex with compound fu58-2 |
|
87
|
330
|
5sanA |
Endothiapepsin in complex with compound fu5-4 |
|
86
|
330
|
5sasA |
Endothiapepsin in complex with compound fu290-2 |
|
87
|
330
|
5sarA |
Endothiapepsin in complex with compound fu290-1 |
|
86
|
330
|
5satA |
Endothiapepsin in complex with compound fu66-1 |
|
87
|
330
|
5samA |
Endothiapepsin in complex with compound fu5-3 |
|
85
|
330
|
5saoA |
Endothiapepsin in complex with compound fu58-1 |
|
84
|
330
|
5salA |
Endothiapepsin in complex with compound fu5-2 |
|
87
|
330
|
5saqA |
Endothiapepsin in complex with compound fu58-3 |
|
85
|
330
|
5sakA |
Endothiapepsin in complex with compound fu5-1 |
|
102
|
390
|
7myuA |
Bace-1 in complex with compound #22 |
|
110
|
391
|
7myiA |
Bace-1 in complex with compound #6 |
|
107
|
391
|
7myrA |
Bace-1 in complex with compound #18 |
|
97
|
390
|
7d36A |
Crystal structure of bace1 in complex with n-{3-[(3s)-1-amino-5-fluoro-3-methyl-3,4-dihydro-2,6-naphthyridin-3-yl]-4-fluorophenyl}-5-cyano-3-methylpyridine-2-carboxamide |
|
80
|
326
|
6xcyA |
Porcine pepsin in complex with ritonavir |
|
84
|
326
|
6xd2A |
Porcine pepsin in complex with darunavir |
|
81
|
326
|
6xczA |
Porcine pepsin in complex with saquinavir |
|
82
|
326
|
6xctA |
Porcine pepsin in complex with amprenavir |
|
94
|
339
|
7agcA |
Protease sapp1p from candida parapsilosis in complex with kb74 |
|
94
|
339
|
7ageA |
Protease sapp1p from candida parapsilosis in complex with kb32 |
|
98
|
339
|
7agbA |
Protease sapp1p from candida parapsilosis in complex with kb70 |
|
100
|
339
|
7agdA |
Protease sapp1p from candida parapsilosis in complex with kb75 |
|
97
|
391
|
7d2vA |
Crystal structure of bace1 in complex with n-{3-[(5r)-3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2h-1lambda6,2,4-thiadiazin-5-yl]-4-fluorophenyl}-5-fluoropyridine-2-carboxamide |
|
95
|
383
|
7d5uA |
Bace2 xaperone complex with n-{3-[(9s)-7-amino-2,2-difluoro-9-(prop-1-yn-1-yl)-6-oxa-8-azaspiro[3.5]non-7-en-9-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide |
|
94
|
389
|
7d5aA |
Crystal structure of bace1 in complex with n-{3-[(9s)-7-amino-2,2-difluoro-9-(prop-1-yn-1-yl)-6-oxa-8-azaspiro[3.5]non-7-en-9-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide |
|
101
|
389
|
7d2xA |
Crystal structure of bace1 in complex with n-{3-[(4r)-2-amino-4-(prop-1-yn-1-yl)-5,6-dihydro-4h-1,3-oxazin-4-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide |
|
98
|
385
|
7d5bA |
Bace2 xaperone complex with n-{3-[(5r)-3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2h-1lambda6,2,4-thiadiazin-5-yl]-4-fluorophenyl}-5-fluoropyridine-2-carboxamide |
|
93
|
350
|
6r61A |
Major aspartyl peptidase 1 from c. neoformans in complex with inhibitor lp258 |
|
89
|
350
|
6r6aA |
Major aspartyl peptidase 1 from c. neoformans |
|
93
|
350
|
6r5hA |
Major aspartyl peptidase 1 from c. neoformans |
|
91
|
390
|
7dczA |
Crystal structure of bace1 in complex with n-{3-[(4s)-2-amino-4-methyl-4h-1,3-thiazin-4-yl]-4- fluorophenyl}-5-cyanopyridine-2-carboxamide |
|
114
|
545
|
6orsA |
Structure of plasmepsin x (pm10, pmx) from plasmodium falciparum 3d7 |
|
77
|
382
|
6uj1A |
Bace2 mutant in complex with a macrocyclic compound |
|
89
|
381
|
6uj0A |
Unbound bace2 mutant structure |
|
83
|
330
|
6scvA |
Endothiapepsin in complex with ligand 69 |
|
82
|
377
|
6kudA |
Crystal structure of plasmodium falciparum histo-aspartic protease (hap) zymogen (form 3) |
|
84
|
380
|
6kubA |
Crystal structure of plasmodium falciparum histo-aspartic protease (hap) zymogen (form 1) |
|
79
|
377
|
6kucA |
Crystal structure of plasmodium falciparum histo-aspartic protease (hap) zymogen (form 2) |
|
87
|
330
|
5rchA |
Pandda analysis group deposition -- endothiapepsin ground state model 02 |
|
86
|
330
|
5re1A |
Pandda analysis group deposition -- endothiapepsin ground state model 58 |
|
89
|
330
|
5rc9A |
Pandda analysis group deposition -- endothiapepsin changed state model for fragment f2x-entry library g03b |
|
89
|
330
|
5rbzA |
Pandda analysis group deposition -- endothiapepsin changed state model for fragment f2x-entry library e05a |
|
87
|
330
|
5rciA |
Pandda analysis group deposition -- endothiapepsin ground state model 03 |
|
87
|
330
|
5rdzA |
Pandda analysis group deposition -- endothiapepsin ground state model 56 |
|
90
|
330
|
5rc3A |
Pandda analysis group deposition -- endothiapepsin changed state model for fragment f2x-entry library f03a |
|
86
|
330
|
5rcyA |
Pandda analysis group deposition -- endothiapepsin ground state model 20 |
